SD Cyber Security
Healthcare / Biotech
SOC 2
Torrey Pines, SD

Biotech Startup Achieves SOC 2 and Secures $12M Enterprise Partnership

How a 75-person San Diego biotech company went from zero formal security to SOC 2 Type I in 10 weeks.

Industry

Biotech / Pharma

Employees

75

Location

Torrey Pines, SD

Timeline

10 weeks

The Challenge

A San Diego biotech company developing novel therapeutics was in advanced negotiations for a $12M partnership with a Fortune 500 pharmaceutical company. The deal included sharing preclinical data and integrating research platforms -- but the enterprise partner required SOC 2 Type I certification as a prerequisite for data sharing.

The problem: the company had no formal security program. Their IT was managed by a two-person team focused on keeping systems running, not security. There was no documented security policy, no access reviews, no centralized logging, and no incident response plan. The deal had a 90-day deadline.

Initial Gap Assessment Findings

No documented information security policies
No multi-factor authentication on any systems
No centralized log collection or monitoring
No endpoint detection and response (EDR)
No formal access reviews or least-privilege enforcement
No incident response plan or backup testing
Shared admin credentials across the IT team
Research data accessible to all employees without access controls

Our Approach

We mobilized a dedicated team within 48 hours of engagement. The approach was designed for speed without sacrificing substance -- every control implemented would hold up under audit scrutiny and provide real security value, not just checkbox compliance.

Weeks 1-2: Foundation

Weeks 3-5: Policy and Controls

Weeks 6-8: Training and Testing

Weeks 9-10: Audit Preparation and Execution

Results

SOC 2 Type I

Achieved in 10 weeks with zero exceptions

90% reduction

In critical vulnerabilities within 30 days

$12M deal closed

Enterprise partnership secured on schedule

24/7 monitoring

MDR coverage established from week 2

Long-Term Impact

The SOC 2 certification became a competitive advantage. Within six months, the company closed two additional enterprise partnerships that required security attestation. They transitioned to SOC 2 Type II with a 12-month observation window, further strengthening their market position in San Diego’s competitive biotech landscape.

The security program we built did not just satisfy auditors -- it prevented two phishing attempts and one credential-stuffing attack during the first year of monitoring, protecting research data worth significantly more than the investment in security.